Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

Lupin has received USFDA approval for generic diabetes medications, specifically Liraglutide Injection and Glucagon for ...

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

Researchers analyzed 11 different studies to understand weight outcomes after stopping anti-obesity medications called ...

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the ...

Researchers analyzed 11 different studies to understand weight outcomes after stopping anti-obesity medications called ...

Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...

Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...